Whole-body magnetic resonance imaging provides accurate staging of diffuse large B-cell lymphoma, but is less preferred by patients

被引:1
作者
Lambert, Lukas [1 ,2 ]
Wagnerova, Monika [3 ,4 ]
Vodicka, Prokop [4 ,5 ]
Benesova, Katerina [4 ,5 ]
Zogala, David [4 ,6 ]
Trneny, Marek [4 ,5 ]
Burgetova, Andrea [3 ,4 ]
机构
[1] Charles Univ Prague, Motol Univ Hosp, Dept Imaging Methods, V Uvalu 84, Prague 5, Czech Republic
[2] Charles Univ Prague, Fac Med 2, V Uvalu 84, Prague 5, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Dept Radiol, Prague 12808, Czech Republic
[4] Gen Univ Hosp Prague, Prague 12808, Czech Republic
[5] Charles Univ Prague, Fac Med 1, Dept Med 1, Prague 12808, Czech Republic
[6] Charles Univ Prague, Inst Nucl Med, Fac Med 1, Prague 12808, Czech Republic
关键词
Diffuse large B-cell lymphoma; Magnetic resonance imaging; Positron emission tomography/computed tomography; Staging; Preference; FDG-PET/CT; RESPONSE ASSESSMENT; MRI; COMPLETION; DLBCL; CHOP;
D O I
10.4329/wjr.v17.i1.99207
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BACKGROUND Whole-body magnetic resonance imaging (wbMRI) allows general assessment of systemic cancers including lymphomas without radiation burden. AIM To evaluate the diagnostic performance of wbMRI in the staging of diffuse large B-cell lymphoma (DLBCL), determine the value of individual MRI sequences, and assess patients' concerns with wbMRI. METHODS In this single-center prospective study, adult patients newly diagnosed with systemic DLBCL underwent wbMRI on a 3T scanner [diffusion weighted images with background suppression (DWIBS), T2, short tau inversion recovery (STIR), contrast-enhanced T1] and fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) (reference standard). The involvement of 12 nodal regions and extranodal sites was evaluated on wbMRI and PET/CT. The utility of wbMRI sequences was rated on a five-point scale (0 = not useful, 4 = very useful). Patients received a questionnaire regarding wbMRI. RESULTS Of 60 eligible patients, 14 (23%) were enrolled and completed the study. The sensitivity of wbMRI in the nodal involvement (182 nodal sites) was 0.84, with 0.99 specificity, positive predictive value of 0.96, negative predictive value of 0.97, and 0.97 accuracy. PET/CT and wbMRI were concordant both in extranodal involvement (13 instances) and staging (kappa = 1.0). The mean scores of the utility of MRI sequences were 3.71 +/- 0.73 for DWIBS, 2.64 +/- 0.84 for T1, 2.14 +/- 0.77 for STIR, and 1.29 +/- 0.73 for T2 (P < 0.0001). Patients were mostly concerned about the enclosed environment and duration of the MRI examination (27% of patients). CONCLUSION The wbMRI exhibited excellent sensitivity and specificity in staging DLBCL. DWIBS and contrast-enhanced T1 were rated as the most useful sequences. Patients were less willing to undergo wbMRI as a second examination parallel to PET/CT, especially owing to the long duration and the enclosed environment.
引用
收藏
页数:12
相关论文
共 31 条
[1]   Accelerated Diffusion-Weighted MR Image Reconstruction Using Deep Neural Networks [J].
Aamir, Fariha ;
Aslam, Ibtisam ;
Arshad, Madiha ;
Omer, Hammad .
JOURNAL OF DIGITAL IMAGING, 2023, 36 (01) :276-288
[2]  
Abdel-aziz SMA., 2021, QJM, V114
[3]   Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients [J].
Abdulqadhr, Goran ;
Molin, Daniel ;
Astrom, Gunnar ;
Suurkula, Madis ;
Johansson, Lars ;
Hagberg, Hans ;
Ahlstrom, Hakan .
ACTA RADIOLOGICA, 2011, 52 (02) :173-180
[4]   PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular Lymphomas [J].
Barrington, Sally F. ;
Mikhaeel, N. George .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (03) :185-195
[5]   Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification [J].
Cheson, Bruce D. ;
Fisher, Richard I. ;
Barrington, Sally F. ;
Cavalli, Franco ;
Schwartz, Lawrence H. ;
Zucca, Emanuele ;
Lister, T. Andrew .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3059-+
[6]   Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte [J].
Coiffier, Bertrand ;
Thieblemont, Catherine ;
Van Den Neste, Eric ;
Lepeu, Gerard ;
Plantier, Isabelle ;
Castaigne, Sylvie ;
Lefort, Sophie ;
Marit, Gerald ;
Macro, Margaret ;
Sebban, Catherine ;
Belhadj, Karim ;
Bordessoule, Dominique ;
Ferme, Christophe ;
Tilly, Herve .
BLOOD, 2010, 116 (12) :2040-2045
[7]   Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up [J].
Davies, Andrew J. ;
Barrans, Sharon ;
Stanton, Louise ;
Caddy, Josh ;
Wilding, Sam ;
Saunders, Geoff ;
Mamot, Christoph ;
Novak, Urban ;
McMillan, Andrew ;
Fields, Paul ;
Collins, Graham P. ;
Stephens, Richard ;
Cucco, Francesco ;
Sha, Chulin L. ;
van Hoppe, Moniek ;
Tooze, Reuben ;
Davies, John R. ;
Griffiths, Gareth ;
Schuh, Anna ;
Burton, Catherine ;
Westhead, David R. ;
Du, Ming-Qing ;
Johnson, Peter W. M. .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (15) :2718-+
[8]   PET/CT for Staging; Past, Present, and Future [J].
El-Galaly, Tarec Christoffer ;
Gormsen, Lars Christian ;
Hutchings, Martin .
SEMINARS IN NUCLEAR MEDICINE, 2018, 48 (01) :4-16
[9]   Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole-body diffusion-weighted MRI (ISAAC study) [J].
Fischerova, D. ;
Pinto, P. ;
Burgetova, A. ;
Masek, M. ;
Slama, J. ;
Kocian, R. ;
Fruhauf, F. ;
Zikan, M. ;
Dusek, L. ;
Dundr, P. ;
Cibula, D. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2022, 59 (02) :248-262
[10]   Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma [J].
Hagtvedt, Trond ;
Seierstad, Therese ;
Lund, Kjersti V. ;
Londalen, Ayca M. ;
Bogsrud, Trond V. ;
Smith, Hans-Jorgen ;
Geier, Oliver M. ;
Holte, Harald ;
Aalokken, Trond Mogens .
ACTA RADIOLOGICA, 2015, 56 (02) :152-158